Search results
Kim Kardashian’s Met Gala Look Had 1 Detail So Extreme It Made People Uncomfortable
HuffPost· 1 day agoKim Kardashian courted controversy at Monday’s Met Gala due to a very uncomfortable-looking aspect...
3 Tried and True Dividend Stocks to Buy for Your Portfolio
InvestorPlace· 1 day agoPicking income stocks can be challenging. It varies year to year, but holding solid income stocks...
Amjevita and dosage: Strengths, forms, how to inject, and more
Medical News Today· 6 days agoAmjevita comes as a solution subcutaneous injection. Your doctor will determine the best dosage to...
Motley Fool Wealth Management LLC Cuts Position in Johnson & Johnson (NYSE:JNJ)
ETF DAILY NEWS· 6 days agoMotley Fool Wealth Management LLC decreased its position in shares of Johnson & Johnson (NYSE:JNJ – Free Report) by 11.1% during the fourth quarter, according to the company in its most recent ...
Janssen-Cilag seeks expanded EMA approval for TREMFYA
Pharmaceutical Technology via Yahoo Finance· 7 days agoGuselkumab has been approved in the EU to treat moderate to severe plaque psoriasis in adults who...
MoonLake Immunotherapeutics Reports Q1 2024 Financial Outcomes
Guru Focus· 1 day agoReported Net Loss: $13.98 million for Q1 2024, below the estimated net loss of $13.21 million.Earnings Per Share (EPS): Recorded a loss of $0.22 per share, bel
Russell Investments Group Ltd. Has $283.28 Million Stock Position in Johnson & Johnson (NYSE:JNJ)
ETF DAILY NEWS· 6 days agoRussell Investments Group Ltd. lowered its stake in Johnson & Johnson (NYSE:JNJ – Free Report) by 5.2% during the fourth quarter, according to the company in its most recent filing with the ...
13 Times Met Gala Attendees Took "Beauty Is Pain" Way Too Seriously And Wore Looks That Physically...
BuzzFeed via Yahoo News· 5 days agoFor Kim Kardashian, wearing her famous Mugler "wet look" dress was one of the most painful...
Pharma Stock Roundup: LLY, NVO, PFE Q1 Results, JNJ's New Plan to Resolve Talc Claims
Zacks via Yahoo Finance· 5 days agoTremfya is presently approved to treat certain patients with plaque psoriasis and active psoriatic ...
Kymera (KYMR) Q1 Loss Narrower Than Expected, Pipeline in Focus
Zacks via Yahoo Finance· 6 days agoKymera (KYMR) reports a narrower-than-expected loss in the first quarter. The company expects the...